Original Research

Urologist Workforce Variation Across the VHA

Author and Disclosure Information

 

References

Limitations

This study should be interpreted in the context of several limitations. First, FY 2011 data were used; notably, the VHA urologist workforce remained relatively stable from 2008 through 2011. Second, characteristics of individual VHA urologists, clinical productivity, and skill level were not examined. However, a 2008 study found that nearly all VHA urologists are board certified, mitigating skill level concerns.14 Third, it is possible that demand is partially driven by existence of resources, and there may be patients who might benefit from urologic care but who are not yet diagnosed. The analysis is conservative in this regard, in that demand may be greater than what was detected using the selected study methods. Last, this study examined specialist workforce within a single system. However, ensuring specialist resources are well distributed is a concern for most health systems, particularly in light of recent policy efforts, including accountable care organizations.15

Conclusion

Much of the variation in the VHA urologist workforce exists at the facility rather than the regional level. Optimizing the distribution of these specialty care resources could be achieved through novel care delivery models within each regional network that are well-aligned with current VHA initiatives. Successfully utilizing this workforce distribution has the potential to improve urologic care for veterans across the country and could be applied to improve access to all types of specialists in underserved and understaffed areas.

Acknowledgments
Dr. Skolarus is supported by a VA HSR&D Career Development Award (CDA 12-171).

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Pages

Recommended Reading

Tackling a Delicate Subject With Heart Failure Patients
Federal Practitioner
Urology: Engineered for the New Millennium
Federal Practitioner
Postoperative Gum Chewing; The Importance of Prostate Screening Discussions
Federal Practitioner
Know Your Prostate
Federal Practitioner
Medicare vs VA—VA Wins; Delaying Antibiotics for UTI; Dolutegravir Approved to Treat Resistant HIV Infection
Federal Practitioner
Antibiotic Therapy and Bacterial Resistance in Patients With Spinal Cord Injury
Federal Practitioner
Recurrent Multidrug Resistant Urinary Tract Infections in Geriatric Patients
Federal Practitioner
Battling Multidrug Resistant UTIs With Methenamine Hippurate
Federal Practitioner
Recovering From Military Sexual Trauma
Federal Practitioner
Decrease of Sexual Violence on Military Campuses Is Not Enough
Federal Practitioner

Related Articles